News coverage about National Health Investors (NYSE:NHI) has trended somewhat positive this week, Accern Sentiment reports. The research group rates the sentiment of press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. National Health Investors earned a media sentiment score of 0.12 on Accern’s scale. Accern also gave news headlines about the real estate investment trust an impact score of 46.8212351693604 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
A number of analysts recently commented on the stock. Stephens set a $79.00 price objective on shares of National Health Investors and gave the stock a “buy” rating in a report on Friday, January 12th. Cantor Fitzgerald reissued a “hold” rating and set a $85.00 price objective on shares of National Health Investors in a research note on Wednesday, January 17th. SunTrust Banks set a $75.00 price objective on shares of National Health Investors and gave the company a “hold” rating in a research note on Monday, January 22nd. KeyCorp reissued a “hold” rating on shares of National Health Investors in a research note on Friday, November 24th. Finally, Hilliard Lyons raised shares of National Health Investors from a “neutral” rating to a “buy” rating in a research report on Friday, February 16th. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $77.75.
National Health Investors (NYSE:NHI) opened at $68.28 on Wednesday. The company has a current ratio of 13.85, a quick ratio of 13.85 and a debt-to-equity ratio of 0.87. National Health Investors has a 52 week low of $62.71 and a 52 week high of $81.60. The company has a market cap of $2,849.94, a price-to-earnings ratio of 17.64, a price-to-earnings-growth ratio of 3.54 and a beta of 0.48.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 10th. Investors of record on Friday, March 30th will be issued a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a dividend yield of 5.86%. The ex-dividend date of this dividend is Wednesday, March 28th. This is a boost from National Health Investors’s previous quarterly dividend of $0.95. National Health Investors’s dividend payout ratio (DPR) is 98.19%.
In related news, CEO D. Eric Mendelsohn bought 2,000 shares of the stock in a transaction on Thursday, February 22nd. The shares were purchased at an average price of $65.47 per share, with a total value of $130,940.00. Following the purchase, the chief executive officer now owns 10,580 shares in the company, valued at $692,672.60. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP John L. Spaid bought 500 shares of the stock in a transaction on Thursday, February 22nd. The shares were bought at an average cost of $64.95 per share, for a total transaction of $32,475.00. Following the purchase, the vice president now owns 971 shares in the company, valued at approximately $63,066.45. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 2,812 shares of company stock worth $183,910. Corporate insiders own 5.19% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This report was posted by BBNS and is the sole property of of BBNS. If you are accessing this report on another website, it was illegally stolen and republished in violation of international copyright laws. The correct version of this report can be read at https://baseballnewssource.com/2018/03/14/national-health-investors-nhi-getting-somewhat-positive-news-coverage-study-shows/1971307.html.
About National Health Investors
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.